Genetic Association of Lipid-Lowering Drugs with Aortic Aneurysms: A Mendelian Randomization Study

Author:

Gao Xiong1ORCID,Luo Wei1,Qu Liyuan2,Yang Miaomiao1,Chen Siyu1,Lei Li3,Yan Shaohua1,Liang Hongbin1,Zhang Xinlu1,Xiao Min1,Liao Yulin1ORCID,Lee Alex Pui-Wai4,Zhou Zhongjiang1,Chen Jiejian5,Zhang Qiuxia1ORCID,Wang Yuegang1ORCID,Xiu Jiancheng1ORCID

Affiliation:

1. Department of Cardiovascular Medicine, Nanfang Hospital, Southern Medical University , 1838 Guangzhou Avenue North, Baiyun District, Guangzhou City, Guangdong Province , China

2. Department of Endocrinology, Boluo County People’s Hospital , No.1 Kangbo West Road, Luoyang Street, Boluo County, Huizhou City, Guangdong Province , China

3. Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology) , 1017 Dongmen North Road, Luohu District, Shenzhen, Guangdong , China

4. The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administrative Region , China

5. Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology , No.1 Panfu Road, Yuexiu District, Guangzhou City, Guangdong Province , China

Abstract

Abstract Aims The lack of effective pharmacotherapies for aortic aneurysms (AA) is a persistent clinical challenge. Lipid metabolism plays an essential role in AA. However, the impact of lipid-lowering drugs on AA remains controversial. The study aimed to investigate the genetic association between lipid-lowering drugs and AA. Methods Our research used publicly available data on genome-wide association studies (GWASs) and expression quantitative trait loci (eQTL) studies. Genetic instruments, specifically eQTLs related to drug-target genes and SNPs (single nucleotide polymorphisms) located near or within the drug-target loci associated with low-density lipoprotein cholesterol (LDL-C), have been served as proxies for lipid-lowering medications. Drug-Target Mendelian Randomization (MR) study is used to determine the causal association between lipid-lowering drugs and different types of AA. Results The MR analysis revealed that higher expression of HMGCR (3-hydroxy-3-methylglutaryl coenzyme A reductase) was associated with increased risk of AA (OR = 1.58, 95% CI = 1.20-2.09, p = 1.20 × 10−03) and larger lumen size (aortic maximum area: OR = 1.28, 95% CI = 1.13-1.46, p = 1.48 × 10−04; aortic minimum area: OR = 1.26, 95% CI = 1.21-1.42, p = 1.78 × 10−04). PCSK9 (Proprotein convertase subtilisin/kexin type 9) and CETP (Cholesteryl ester transfer protein) show a suggestive relationship with AA (PCSK9: OR = 1.34, 95% CI = 1.10-1.63, p = 3.07 × 10−03; CETP: OR = 1.38, 95% CI = 1.06-1.80, p = 1.47 × 10−02). No evidence to support genetically mediated NPC1L1 (Niemann-Pick C1-Like 1) and LDLR (low-density lipoprotein cholesterol receptor) are associated with AA. Conclusions This study provides causal evidence for the genetic association between lipid-lowering drugs and aortic aneurysms. Higher gene expression of HMGCR, PCSK9, and CETP increases AA risk. Furthermore, HMGCR inhibitors may link with smaller aortic lumen size.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3